Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert Oosterwijk

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinomaAdrienne H Brouwers, Peter F A Mulders, Pieter H M de Mulder, et al.
Tissue Engineering. Part A|March 22, 2017
Bladder Regeneration Using Multiple Acellular Scaffolds with Growth Factors in a BladderLuc A J Roelofs, Paul K J D de Jonge, Egbert Oosterwijk, et al.
European Urology|December 27, 2015
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell CarcinomaConstantijn H J Muselaers, Marye J Boers-Sonderen, Tim J van Oostenbrugge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2014
Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinomaConstantijn H J Muselaers, Alexander B Stillebroer, Ingrid M E Desar, et al.
Journal of the American Society of Nephrology : JASN|March 25, 2005
Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodiesJoost F M Lensen, Angelique L W M M Rops, Tessa J M Wijnhoven, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancerJohn Dulos, Gregory J Carven, Susan J van Boxtel, et al.
Cancer Cell|March 5, 2004
Aminopeptidase A is a functional target in angiogenic blood vesselsSerena Marchiò, Johanna Lahdenranta, Reinier O Schlingemann, et al.
Endocrine Connections|October 18, 2017
GATA transcription factors in testicular adrenal rest tumoursManon Engels, Paul N Span, Rod T Mitchell, et al.
Clinical & Translational Immunology|March 12, 2021
Lysine methyltransferase G9a is an important modulator of trained immunityVera P Mourits, Jelmer H van Puffelen, Boris Novakovic, et al.
Plos Pathogens|October 31, 2014
Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancerKathrin Buffen, Marije Oosting, Jessica Quintin, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinomaAdrienne H Brouwers, Peter F A Mulders, Pieter H M de Mulder, et al.
Tissue Engineering. Part A|March 22, 2017
Bladder Regeneration Using Multiple Acellular Scaffolds with Growth Factors in a BladderLuc A J Roelofs, Paul K J D de Jonge, Egbert Oosterwijk, et al.
European Urology|December 27, 2015
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell CarcinomaConstantijn H J Muselaers, Marye J Boers-Sonderen, Tim J van Oostenbrugge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2014
Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinomaConstantijn H J Muselaers, Alexander B Stillebroer, Ingrid M E Desar, et al.
Journal of the American Society of Nephrology : JASN|March 25, 2005
Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodiesJoost F M Lensen, Angelique L W M M Rops, Tessa J M Wijnhoven, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancerJohn Dulos, Gregory J Carven, Susan J van Boxtel, et al.
Cancer Cell|March 5, 2004
Aminopeptidase A is a functional target in angiogenic blood vesselsSerena Marchiò, Johanna Lahdenranta, Reinier O Schlingemann, et al.
Endocrine Connections|October 18, 2017
GATA transcription factors in testicular adrenal rest tumoursManon Engels, Paul N Span, Rod T Mitchell, et al.
Clinical & Translational Immunology|March 12, 2021
Lysine methyltransferase G9a is an important modulator of trained immunityVera P Mourits, Jelmer H van Puffelen, Boris Novakovic, et al.
Plos Pathogens|October 31, 2014
Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancerKathrin Buffen, Marije Oosting, Jessica Quintin, et al.
Pageof 19